Total hip arthroplasty in hip tuberculosis: a systematic review.

Publication date: Jan 14, 2025

Tuberculosis of the hip joint is a common form of bone tuberculosis that can cause severe joint destruction and affect quality of life. Total hip arthroplasty (THA) is an important way to treat hip joint-related diseases. In recent years, THA has been applied to treat tuberculosis of the hip joint and has achieved certain results. To this end, we conducted a systematic review of total hip arthroplasty (THA) for the treatment of tuberculosis of the hip. We searched six electronic databases, including the CNKI Database, Wanfang Database, PubMed, Web of Science, Embase, and Cochrane Library, to systematically review and evaluate the literature on hip replacement in patients with acute tuberculative coxitis from the establishment of the database until July 2024. The results of the analysis included patient demographic characteristics, clinical presentation, antituberculosis therapy and surgical protocols, and surgical outcomes. A meta-analysis was performed if the data were available. Among a total of 1843 articles, 38 studies were selected, of which 24 studies reported relevant data for meta-analysis. A total of 855 patients (mean age: 34 to 57 years, mean follow-up: 0. 5 to 11 years) were enrolled. In general, physicians are accustomed to deciding the appropriate timing of surgery based on inflammatory markers; 90% of the studies recommended preoperative and postoperative antituberculosis therapy (ATT), and 14 studies used antituberculosis drugs during surgery. The majority of the studies used single-stage surgery, and 6 studies used two-stage surgery; cemented prostheses were used in 19. 6% of the surgeries, cementless prostheses were used in 79. 5% of the surgeries, and hybrid fixation was used in 0. 9% of the surgeries. The lateral and posterior approaches were dominant in the included studies. In all the studies, 34 patients experienced disease reactivation. The average complication(defective healing, followed by aseptic loosening, dislocation, deep venous thrombosis, and so on) rate was 11. 2%(39/300 cases). The mean Harris hip score (HHS) at the final follow-up was 89. 05. THA is an effective method for treating tubercular arthritis of the hip. In the past, it was thought to increase the risk of disease reactivation, but studies have shown generally favorable results, THA could significantly improve patients’ quality of life. Two-stage surgery can be used in complex patients at greater risk. A long course of multidrug antituberculosis therapy is crucial for preventing reactivation and enhancing the effectiveness of surgery.

Open Access PDF

Concepts Keywords
11years Hip
Bone Systematic review
Library THA
Surgeries Total hip arthroplasty
Tuberculosis Tubercular arthritis
Tuberculosis

Semantics

Type Source Name
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH bone tuberculosis
disease IDO quality
drug DRUGBANK Tacrine
drug DRUGBANK 5-amino-1 3 4-thiadiazole-2-thiol
disease MESH deep venous thrombosis
disease MESH arthritis
pathway REACTOME Reproduction
disease MESH spinal tuberculosis
disease MESH abscess
disease MESH infection
disease MESH deformity
disease MESH joint pain
disease MESH complications
disease IDO country
disease MESH pulmonary tuberculosis
disease MESH inflammation
drug DRUGBANK Rifampicin
drug DRUGBANK Streptomycin
drug DRUGBANK Isoniazid
drug DRUGBANK Trestolone
disease MESH mixed infection
disease MESH postoperative pain
disease MESH recurrence
drug DRUGBANK Pyrazinamide
drug DRUGBANK Ethambutol
drug DRUGBANK Levofloxacin
disease IDO intervention
disease MESH defects
drug DRUGBANK Vancomycin
disease IDO process
disease IDO bactericidal
drug DRUGBANK Indoleacetic acid
disease MESH periprosthetic fractures
disease MESH sciatic neuropathy
drug DRUGBANK Guanosine
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH Misdiagnosis

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *